.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

The Risk of Recurrence in HR+/HER2- Early Breast Cancer

April 14, 2025

Author(s): Sponsored by Novartis

Learn more about the risk of recurrence in HR+/HER2- early breast cancer.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00